{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:40:54Z","timestamp":1791639654465,"version":"4.3.4"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06393-6","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:59:01Z","timestamp":1765540741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["RETRACTED ARTICLE: Phage therapy and the microbiome in hematologic malignancies: opportunities, mechanisms, and early evidence"],"prefix":"10.1007","volume":"152","author":[{"given":"Juanwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1882-9471","authenticated-orcid":false,"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-3512","authenticated-orcid":false,"given":"Alireza","family":"Bayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"6393_CR1","doi-asserted-by":"crossref","unstructured":"Abedon ST (2019) Phage-Antibiotic combination treatments: antagonistic impacts of antibiotics on the pharmacodynamics of phage therapy? Antibiot (Basel), 8","DOI":"10.3390\/antibiotics8040182"},{"key":"6393_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A AGUS","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H (2021) Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70:1174\u20131182","journal-title":"Gut"},{"key":"6393_CR3","doi-asserted-by":"publisher","first-page":"100081","DOI":"10.1016\/j.glmedi.2024.100081","volume":"2","author":"SK AHMED","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, Ibrahim, R. H., Fareeq, A., Mahmood, K. A., Mohamed MG (2024) Antimicrobial resistance: Impacts, challenges, and future prospects. J Med Surg Public Health 2:100081","journal-title":"J Med Surg Public Health"},{"key":"6393_CR4","doi-asserted-by":"crossref","unstructured":"Akkaya M, Miozzo Akkayab, Rawat P, Pena M, Kim Msheehanpw, Kamenyeva AS, Chaturvedi Okabatjbollands A. & Pierce, S. K. B (2017) Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids. J Immunol, 199, 931\u2013940","DOI":"10.4049\/jimmunol.1700348"},{"key":"6393_CR5","doi-asserted-by":"crossref","unstructured":"Alam MZ, Maslanka, J. R., Abt MC (2023) Immunological consequences of microbiome-based therapeutics. Front Immunol, Volume 13\u20132022","DOI":"10.3389\/fimmu.2022.1046472"},{"key":"6393_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/NSA.S325594","volume":"14","author":"S AMANKWAH","year":"2021","unstructured":"Amankwah S, Abdella K, Kassa T (2021) Bacterial biofilm destruction: A focused review on the recent use of Phage-Based strategies with other antibiofilm agents. Nanotechnol Sci Appl 14:161\u2013177","journal-title":"Nanotechnol Sci Appl"},{"key":"6393_CR7","doi-asserted-by":"crossref","unstructured":"Aranaga C, Pantoja, L. D., Mart\u00ednez, E. A., Falco A (2022) Phage therapy in the era of multidrug resistance in bacteria: A systematic review. Int J Mol Sci, 23","DOI":"10.3390\/ijms23094577"},{"key":"6393_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10238-025-01724-w","volume":"25","author":"A BAYANI","year":"2025","unstructured":"Bayani A, Abosaoda MK, Nazari Rizaevj, Jafari M, Soleimani Samarkhazan, H (2025) Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy. Clin Experimental Med 25:186","journal-title":"Clin Experimental Med"},{"key":"6393_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","volume":"46","author":"Y BELKAID","year":"2017","unstructured":"Belkaid Y, Harrison OJ (2017) Homeostatic immunity and the microbiota. Immunity 46:562\u2013576","journal-title":"Immunity"},{"key":"6393_CR10","doi-asserted-by":"crossref","unstructured":"Bhagwat AS, Torres L, Shestov Shestovao, Farooki Mmellorspwfisherhr, Frost SN, Loken BF, Frazee Mrgaymonal, Frey Drogalw, Mccurdy Nhexnereolugersmlorenawmartinme, Brogdon Srperlaestadtmauerea, Plesa Jlfraiettajahwangwtsiegeldl (2024) Cytokine-mediated CAR T therapy resistance in AML. Nat Med, 30, 3697\u20133708","DOI":"10.1038\/s41591-024-03271-5"},{"key":"6393_CR11","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/microorganisms12112256","volume":"12","author":"S BIENNIER","year":"2024","unstructured":"Biennier S, Fontaine M, Duquenoy A, Schwintner C, Dor\u00e9, J., Corvaia N (2024) Narrative review: advancing dysbiosis treatment in Onco-Hematology with Microbiome-Based therapeutic approach. Microorganisms 12:2256","journal-title":"Microorganisms"},{"key":"6393_CR12","doi-asserted-by":"crossref","unstructured":"Bishoyi AK, Nouri S, Hussen A, Bayani A, Khaksari MN & Soleimani Samarkhazan, H. (2025) Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation. Clinical and Experimental Medicine, 25, 166","DOI":"10.1007\/s10238-025-01686-z"},{"key":"6393_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chom.2019.01.020","volume":"25","author":"PL BOLLYKY","year":"2019","unstructured":"Bollyky PL, Secor PR (2019) The innate sense of bacteriophages. Cell Host Microbe 25:177\u2013179","journal-title":"Cell Host Microbe"},{"key":"6393_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ijid.2008.01.006","volume":"12","author":"J BORYSOWSKI","year":"2008","unstructured":"Borysowski J, G\u00f3rski A (2008) Is phage therapy acceptable in the immunocompromised host? Int J Infect Dis 12:466\u2013471","journal-title":"Int J Infect Dis"},{"key":"6393_CR15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S BULLMAN","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon YCS, Fasani R, Aguirre AJ, NG K, \u00c9lez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M (2017) Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358:1443\u20131448","journal-title":"Science"},{"key":"6393_CR16","doi-asserted-by":"crossref","unstructured":"Cao M, Deng Y, Hao Q, Wu Yanhwangq-ldongc, He J, Huang Y, Gao L-Bxiax, Chen Y, Zhang H-N, Zhang W-H, Zhuo Y-J, Dai X, Zhang Lhuhpengy, Huang Fliuz, Zhang W, H., Yang, L., Shu, Y., Zhang, W., Zhang, Y., XU H (2025) Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment. Signal Transduction and Targeted Therapy, 10, 140","DOI":"10.1038\/s41392-025-02226-7"},{"key":"6393_CR17","doi-asserted-by":"publisher","first-page":"e25029","DOI":"10.4161\/bact.25029","volume":"3","author":"W CENENS","year":"2013","unstructured":"CENENS W, MEBRHATU MAKUMIA, LAVIGNE MT, R., AERTSEN A (2013) Phage-host interactions during pseudolysogeny: lessons from the Pid\/dgo interaction. Bacteriophage 3:e25029","journal-title":"Bacteriophage"},{"key":"6393_CR18","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan BK, Stanley GL, Kortright KE, Vill AC, Modak M, Ott IM, Sun Y, W\u00fcrstle S, Grun CN, Kazmierczak BI, Rajagopalan G, Harris ZM, Britto CJ, Stewart J, Talwalkar JS, Appell CR, Chaudary N, Jagpal SK, Jain R, Kanu A, Quon BS, Reynolds JM, Teneback CC, Mai Q-A, Shabanova V, Turner PE, Koff JL (2025) Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat Med 31:1494\u20131501","journal-title":"Nat Med"},{"key":"6393_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00001622-200101000-00005","volume":"13","author":"TR CHAUNCEY","year":"2001","unstructured":"Chauncey TR (2001) Drug resistance mechanisms in acute leukemia. Curr Opin Oncol 13:21\u201326","journal-title":"Curr Opin Oncol"},{"key":"6393_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40168-017-0250-1","volume":"5","author":"LL CHUA","year":"2017","unstructured":"Chua LL, Abdullah Rajasuriarrazananms, Woo Nktangmsleesc, Lim YL, Ariffin YA, H., Loke P (2017) Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation. Microbiome 5:35","journal-title":"Microbiome"},{"key":"6393_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2011-300367","volume":"61","author":"MA CIORBA","year":"2012","unstructured":"Ciorba MA, Riehl TE, Rao MS, Moon C, Ee X, Walker Navagm, M. R., Marinshaw, J. M., Stappenbeck, T. S., Stenson WF (2012) Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2\/cyclo-oxygenase-2-dependent manner. Gut 61:829\u2013838","journal-title":"Gut"},{"key":"6393_CR23","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1021\/acs.jafc.9b00080","volume":"67","author":"Y CUI","year":"2019","unstructured":"Cui Y, Wang Q, Zhou Changr, X., Xu C (2019) Intestinal barrier Function-Non-alcoholic fatty liver disease interactions and possible role of gut microbiota. J Agric Food Chem 67:2754\u20132762","journal-title":"J Agric Food Chem"},{"key":"6393_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/antibiotics13090870","volume":"13","author":"L CUI","year":"2024","unstructured":"Cui L, Watanabe S, Kiga Miyanagak, Sasahara K, Aiba T, Tan Y, Veeranarayanan X-E, Thitiananpakorn S, K., Nguyen, H. M., Wannigama DL (2024) A comprehensive review on phage therapy and phage-Based drug development. Antibiotics 13:870","journal-title":"Antibiotics"},{"key":"6393_CR24","doi-asserted-by":"crossref","unstructured":"D\u0105browska K, Abedon ST (2019) Pharmacologically aware phage therapy: pharmacodynamic and Pharmacokinetic Obstacles to phage antibacterial action in animal and human bodies. Microbiol Mol Biol Rev, 83","DOI":"10.1128\/MMBR.00012-19"},{"key":"6393_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM DEDRICK","year":"2019","unstructured":"Dedrick RM, Guerrero-bustamante CA, Ford Garlenararussellda, Harris K, Jacobs-Sera Kgilmourkcsoothillj, D., Schooley, R. T., Hatfull, G. F., Spencer H (2019) Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 25:730\u2013733","journal-title":"Nat Med"},{"key":"6393_CR26","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Barriga C, Villanueva-flores F, Z\u00e1rate-romero Questerk, Cadena-nava A, R. D., Huerta-saquero A (2021) Asparaginase-Phage P22 nanoreactors: toward a biobetter development for acute lymphoblastic leukemia treatment. Pharmaceutics, 13","DOI":"10.3390\/pharmaceutics13050604"},{"key":"6393_CR27","doi-asserted-by":"crossref","unstructured":"Dobosz P, St\u0119pie\u0144 M, Golke, A., Dzieci\u0105tkowski T (2022) Challenges of the immunotherapy: perspectives and limitations of the immune checkpoint inhibitor treatment. Int J Mol Sci, 23","DOI":"10.3390\/ijms23052847"},{"key":"6393_CR28","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.2147\/IDR.S341265","volume":"14","author":"JB DOUB","year":"2021","unstructured":"Doub JB (2021) Risk of bacteriophage therapeutics to transfer genetic material and contain contaminants beyond endotoxins with clinically relevant mitigation strategies. Infect Drug Resist 14:5629\u20135637","journal-title":"Infect Drug Resist"},{"key":"6393_CR29","doi-asserted-by":"publisher","first-page":"1611857","DOI":"10.3389\/fcimb.2025.1611857","volume":"15","author":"MB DOUD","year":"2025","unstructured":"Doud MB, Robertson, J. M., Strathdee SA (2025) Optimizing phage therapy with artificial intelligence: a perspective. Front Cell Infect Microbiol 15:1611857","journal-title":"Front Cell Infect Microbiol"},{"key":"6393_CR30","doi-asserted-by":"publisher","first-page":"2551882","DOI":"10.1080\/19490976.2025.2551882","volume":"17","author":"M EBADI","year":"2025","unstructured":"Ebadi M, Senyshyn Reddis, Minot L, Gooley SS, Lee Tkabageaj, Hill SJ, G. R., Khoruts, A., Rashidi A (2025) Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation. Gut Microbes 17:2551882","journal-title":"Gut Microbes"},{"key":"6393_CR31","doi-asserted-by":"publisher","first-page":"e35666","DOI":"10.1016\/j.heliyon.2024.e35666","volume":"10","author":"F EGHBALPOOR","year":"2024","unstructured":"Eghbalpoor F, Gorji M, Alavigeh, M. Z., Moghadam MT (2024) Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria. Heliyon 10:e35666","journal-title":"Heliyon"},{"key":"6393_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.copbio.2020.11.012","volume":"68","author":"C FAGE","year":"2021","unstructured":"Fage C, Lemire N, Moineau S (2021) Delivery of CRISPR-Cas systems using phage-based vectors. Curr Opin Biotechnol 68:174\u2013180","journal-title":"Curr Opin Biotechnol"},{"key":"6393_CR33","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3324\/haematol.2021.280455","volume":"107","author":"T FAITOV\u00c1","year":"2022","unstructured":"Faitov\u00e1 T, Svanberg R, Da Cunha-Bang C, J\u00f8rgensen Ilettee, Noguera-Julian M, M., Paredes, R., Macpherson, C. R., Niemann CU (2022) The gut Microbiome in patients with chronic lymphocytic leukemia. Haematologica 107:2238\u20132243","journal-title":"Haematologica"},{"key":"6393_CR34","doi-asserted-by":"crossref","unstructured":"Febvre HP, Rao S, Gindin M, Finer Goodwinndm, Lu Evivancojs, S., Manter, D. K., Wallace, T. C., Weir TL (2019) PHAGE Study: Effects of Supplemental Bacteriophage Intake on Inflammation and Gut Microbiota in Healthy Adults. Nutrients, 11","DOI":"10.3390\/nu11030666"},{"key":"6393_CR35","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1182\/blood.2023021174","volume":"143","author":"J FERNANDEZ SANCHEZ","year":"2024","unstructured":"Fernandez Sanchez J, Maknojia, A. A., King KY (2024) Blood and guts: how the intestinal Microbiome shapes hematopoiesis and treatment of hematologic disease. Blood 143:1689\u20131701","journal-title":"Blood"},{"key":"6393_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coph.2020.04.008","volume":"53","author":"S FIORUCCI","year":"2020","unstructured":"Fiorucci S, Baldoni M, Ricci P, Zampella A, Distrutti E, Biagioli M (2020) Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders. Curr Opin Pharmacol 53:45\u201354","journal-title":"Curr Opin Pharmacol"},{"key":"6393_CR37","doi-asserted-by":"crossref","unstructured":"Fran\u00e7a GS, Baron M, Bjornberg Kingbrbossowskijp, Pour A, Rao M, Misirlioglu Apatelas, Barkley S, Dolgalev Dtangkh, Avital Ilibermanda, Chiodin Gkuperwaserf, Papagiannakopoulos Mlevineda, T., Marusyk, A., Lionnet, T., Yanai I (2024) Cellular adaptation to cancer therapy along a resistance continuum. Nature, 631, 876\u2013883","DOI":"10.1038\/s41586-024-07690-9"},{"key":"6393_CR38","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.tim.2017.06.006","volume":"25","author":"J GALLOWAY-PE\u00d1A","year":"2017","unstructured":"Galloway-Pe\u00f1a J, Brumlow, C., Shelburne S (2017) Impact of the microbiota on bacterial infections during cancer treatment. Trends Microbiol 25:992\u20131004","journal-title":"Trends Microbiol"},{"key":"6393_CR39","doi-asserted-by":"crossref","unstructured":"Galloway-Pe\u00f1a JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, Alfayez Daverng, Boddu M (2019) Gut Microbiome Signatures Are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia. Clinical Infectious Diseases, 71, 63\u201371","DOI":"10.1093\/cid\/ciz777"},{"key":"6393_CR40","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/ijc.33908","volume":"150","author":"S GANESAN","year":"2022","unstructured":"Ganesan S, Mathews V, Vyas N (2022) Microenvironment and drug resistance in acute myeloid leukemia: do we know enough? Int J Cancer 150:1401\u20131411","journal-title":"Int J Cancer"},{"key":"6393_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2018.00013","volume":"8","author":"J GAO","year":"2018","unstructured":"Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, Li T, Yin Y (2018) Impact of the gut microbiota on intestinal immunity mediated by Tryptophan metabolism. Front Cell Infect Microbiol 8:13","journal-title":"Front Cell Infect Microbiol"},{"key":"6393_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.aad9378","volume":"352","author":"T GENSOLLEN","year":"2016","unstructured":"Gensollen T, Kasper Iyerss, D. L., Blumberg RS (2016) How colonization by microbiota in early life shapes the immune system. Science 352:539\u2013544","journal-title":"Science"},{"key":"6393_CR43","doi-asserted-by":"crossref","unstructured":"Gopalakrishnan V et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 359, 97\u2013103","DOI":"10.1126\/science.aan4236"},{"key":"6393_CR44","doi-asserted-by":"crossref","unstructured":"Gordillo Altamirano FL, Barr JJ (2019) Phage therapy in the postantibiotic era. Clin Microbiol Rev, 32","DOI":"10.1128\/CMR.00066-18"},{"key":"6393_CR45","doi-asserted-by":"publisher","first-page":"100436","DOI":"10.1016\/j.microb.2025.100436","volume":"8","author":"O GRARI","year":"2025","unstructured":"Grari O, Ezrari S, Yandouzi EL, Benaissa I, Ben E, Lahlou Y, Lahmer M, Elouennass Saddaria, M., Maleb A (2025) A comprehensive review on biofilm-associated infections: Mechanisms, diagnostic challenges, and innovative therapeutic strategies. Microbe 8:100436","journal-title":"Microbe"},{"key":"6393_CR46","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/cid\/ciad335","volume":"77","author":"SI GREEN","year":"2023","unstructured":"Green SI, Santos Clarkjr, Weesner HH, Aslam Kesalazarkc, Blodget Scampbelljwdoernbergsb, Obeid Emorrismisuhga, Silveira K, F. P., Filippov, A. A., Whiteson, K. L., Trautner, B. W., Terwilliger, A. L., Maresso A (2023) A Retrospective, observational study of 12 cases of Expanded-Access customized phage therapy: Production, Characteristics, and clinical outcomes. Clin Infect Dis 77:1079\u20131091","journal-title":"Clin Infect Dis"},{"key":"6393_CR47","doi-asserted-by":"publisher","first-page":"1185787","DOI":"10.3389\/fmicb.2023.1185787","volume":"14","author":"P GUEVARA-RAM\u00cdREZ","year":"2023","unstructured":"Guevara-Ram\u00edrez P, Cadena-Ullauri S, Paz-Cruz E, Tamayo-Trujillo R, Ruiz-Pozo VA, Zambrano AK (2023) Role of the gut microbiota in hematologic cancer. Front Microbiol 14:1185787","journal-title":"Front Microbiol"},{"key":"6393_CR48","doi-asserted-by":"publisher","first-page":"108557","DOI":"10.1016\/j.cclet.2023.108557","volume":"35","author":"L GUO","year":"2024","unstructured":"Guo L, Ding J, Zhou W (2024a) Harnessing bacteria for tumor therapy: current advances and challenges. Chin Chem Lett 35:108557","journal-title":"Chin Chem Lett"},{"key":"6393_CR49","doi-asserted-by":"publisher","first-page":"e34849","DOI":"10.1016\/j.heliyon.2024.e34849","volume":"10","author":"Z GUO","year":"2024","unstructured":"Guo Z, Yuan M, Chai J (2024b) Mini review advantages and limitations of lytic phages compared with chemical antibiotics to combat bacterial infections. Heliyon 10:e34849","journal-title":"Heliyon"},{"key":"6393_CR50","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciy153","volume":"67","author":"H HAKIM","year":"2018","unstructured":"Hakim H, Wolf Dallasr, Tang J, Schultz-Cherry L, Darling S, Johnson V, Jeha Ckarlssoneachangtc, Tuomanen Spuichsunypoundsshaydenrt, E., Rosch JW (2018) Gut Microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis 67:541\u2013548","journal-title":"Clin Infect Dis"},{"key":"6393_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S HANG","year":"2019","unstructured":"Hang S, Paik D, Yao L, Kim E, Lu Trinathj, Ha J, Wu Snelsonbnkellysp, Zheng L, Rastinejad Ylongmanrs, F., Devlin, A. S., Krout, M. R., Fischbach, M. A., Littman, D. R., Huh JR (2019) Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature 576:143\u2013148","journal-title":"Nature"},{"key":"6393_CR52","doi-asserted-by":"publisher","first-page":"e7502","DOI":"10.7717\/peerj.7502","volume":"7","author":"N HASAN","year":"2019","unstructured":"Hasan N, Yang H (2019) Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 7:e7502","journal-title":"PeerJ"},{"key":"6393_CR53","doi-asserted-by":"crossref","unstructured":"Hatoum-Aslan A (2018) Phage Genetic Eng Using CRISPR\u207bCas Syst Viruses, 10","DOI":"10.3390\/v10060335"},{"key":"6393_CR54","doi-asserted-by":"crossref","unstructured":"He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, He H, Liu Tangssuny, Ding F, Zhang X, Y., Hu, S., Xia L (2019) Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. Journal of Biological Engineering, 13, 58","DOI":"10.1186\/s13036-019-0189-9"},{"key":"6393_CR55","doi-asserted-by":"crossref","unstructured":"Hietala V, Horsma-Heikkinen J, Carron A, Skurnik M, Kiljunen S (2019) The removal of Endo- and enterotoxins from bacteriophage preparations. Front Microbiol, Volume 10\u20132019","DOI":"10.3389\/fmicb.2019.01674"},{"key":"6393_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41598-019-57221-0","volume":"10","author":"T HOLTZMAN","year":"2020","unstructured":"Holtzman T, Molshanski-Mor Globusr, Ben-Shem S, Yosef A, I., Qimron U (2020) A continuous evolution system for contracting the host range of bacteriophage T7. Sci Rep 10:307","journal-title":"Sci Rep"},{"key":"6393_CR57","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/intimm\/dxh318","volume":"17","author":"K HONDA","year":"2005","unstructured":"Honda K, Yanai H, Takaoka A, Taniguchi T (2005) Regulation of the type I IFN induction: a current view. Int Immunol 17:1367\u20131378","journal-title":"Int Immunol"},{"key":"6393_CR58","doi-asserted-by":"publisher","first-page":"108252","DOI":"10.1016\/j.jsb.2025.108252","volume":"217","author":"K HOSHI","year":"2025","unstructured":"Hoshi K (2025) Prediction of a structural change in the orientation of the cytoplasmic signaling unit of human Toll-like receptor 9 upon binding of agonistic and antagonistic DNA molecules. J Struct Biol 217:108252","journal-title":"J Struct Biol"},{"key":"6393_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12985-024-02510-y","volume":"21","author":"M HOSSEINI HOOSHIAR","year":"2024","unstructured":"Hosseini Hooshiar M, Salari S, Nasiri K, Saeed Salimus, Yasamineh LM, S., Safaralizadeh R (2024) The potential use of bacteriophages as antibacterial agents in dental infection. Virol J 21:258","journal-title":"Virol J"},{"key":"6393_CR60","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ismej.2017.16","volume":"11","author":"C HOWARD-VARONA","year":"2017","unstructured":"Howard-Varona C, Abedon Hargreaveskr, S. T., Sullivan MB (2017) Lysogeny in nature: mechanisms, impact and ecology of temperate phages. Isme J 11:1511\u20131520","journal-title":"Isme J"},{"key":"6393_CR61","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.scib.2025.01.016","volume":"70","author":"Y HU","year":"2025","unstructured":"Hu Y, Zhou Y, Dai N, Song S, Zhao X, Zhao Y, Cheng L, Lu H, Ge J (2025) Enhancing panvascular medicine: unveiling the nexus of pan-cardio-oncology and expanding therapeutic frontiers. Sci Bull 70:798\u2013800","journal-title":"Sci Bull"},{"key":"6393_CR62","doi-asserted-by":"publisher","first-page":"175883592312048","DOI":"10.1177\/17588359231204854","volume":"15","author":"J HUANG","year":"2023","unstructured":"Huang J, Gong C, Zhou A (2023) Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors. Ther Adv Med Oncol 15:17588359231204854","journal-title":"Ther Adv Med Oncol"},{"key":"6393_CR63","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jmii.2021.02.002","volume":"54","author":"Y-P HUNG","year":"2021","unstructured":"Hung Y-P, Tsai C-S, Tsai Tsaib-Y, Lee P-J, Hsueh Y-T-C-C, P.-R., Lee, C.-C., Ko W-C (2021) Clostridioides difficile infection in patients with hematological malignancy: A multicenter study in Taiwan. J Microbiol Immunol Infect 54:1101\u20131110","journal-title":"J Microbiol Immunol Infect"},{"key":"6393_CR64","doi-asserted-by":"crossref","unstructured":"Islam MM, Mahbub, N. U., Shin, W. S., Oh MH (2024) Phage-encoded depolymerases as a strategy for combating multidrug-resistant acinetobacter baumannii. Front Cell Infect Microbiol, Volume 14\u20132024","DOI":"10.3389\/fcimb.2024.1462620"},{"key":"6393_CR65","doi-asserted-by":"crossref","unstructured":"Jdeed G, Kravchuk B, Tikunova NV (2025) Factors affecting Phage-Bacteria Coevolution dynamics. Viruses, 17","DOI":"10.3390\/v17020235"},{"key":"6393_CR66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ol.2024.14221","volume":"27","author":"H JIANG","year":"2024","unstructured":"Jiang H, Zhang Q (2024) Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review). Oncol Lett 27:87","journal-title":"Oncol Lett"},{"key":"6393_CR67","doi-asserted-by":"publisher","first-page":"155137","DOI":"10.1016\/j.prp.2024.155137","volume":"255","author":"WR KADHUM","year":"2024","unstructured":"Kadhum WR, Saleh Majeedaa, Alhajlah Roalie, Mustafa Salwailyer, Ghildiyal YF, Alawadi P, A., Alsalamy A (2024) Overcoming drug resistance with specific nano scales to targeted therapy: focused on metastatic cancers. Pathol Res Pract 255:155137","journal-title":"Pathol Res Pract"},{"key":"6393_CR68","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.bbmt.2010.05.008","volume":"16","author":"M KAMBOJ","year":"2010","unstructured":"Kamboj M, Chung D, Pamer Seosk, E. G., Sepkowitz, K. A., Jakubowski, A. A., Papanicolaou G (2010) The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transpl 16:1576\u20131581","journal-title":"Biol Blood Marrow Transpl"},{"key":"6393_CR69","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s12032-023-02138-y","volume":"40","author":"S KANNAMPUZHA","year":"2023","unstructured":"Kannampuzha S, Gopalakrishnan AV (2023) Cancer chemoresistance and its mechanisms: associated molecular factors and its regulatory role. Med Oncol 40:264","journal-title":"Med Oncol"},{"key":"6393_CR70","doi-asserted-by":"publisher","first-page":"14532","DOI":"10.1021\/acsnano.3c01295","volume":"17","author":"CY KAO","year":"2023","unstructured":"Kao CY, Pan YC, Hsiao YH, Lim SK, Cheng TW, Huang SW, Wu SM, Sun, C. P., Tao, M. H., Mou KY (2023) Improvement of gene delivery by minimal bacteriophage particles. ACS Nano 17:14532\u201314544","journal-title":"ACS Nano"},{"key":"6393_CR71","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T KAWAI","year":"2010","unstructured":"Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373\u2013384","journal-title":"Nat Immunol"},{"key":"6393_CR72","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/AEM.00096-15","volume":"81","author":"L KHALIFA","year":"2015","unstructured":"Khalifa L, Brosh Y, Gelman D, Coppenhagen-glazer S, Beyth S, Poradosu-Cohen R, Beyth Queya, N., Hazan R (2015) Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol 81:2696\u20132705","journal-title":"Appl Environ Microbiol"},{"key":"6393_CR73","first-page":"e63995","volume":"16","author":"Z KHALIL","year":"2024","unstructured":"Khalil Z, Maher S (2024) The impact of Microbiome dysbiosis on hematopoietic stem cell transplantation outcomes: A review Article. Cureus 16:e63995","journal-title":"Cureus"},{"key":"6393_CR74","doi-asserted-by":"crossref","unstructured":"Khambhati K, Bhattacharjee G, Gohil N, Sagona Dhanoagk, Mani AP, Bui I, Chu NL, Jang Dtkarapurkarjk, Chung SH, H. Y., Maurya, R., Alzahrani, K. J., Ramakrishna, S., Singh V (2023a) Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens. Bioeng Transl Med, 8, e10381","DOI":"10.1002\/btm2.10381"},{"key":"6393_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2023.04.001","volume":"200","author":"K KHAMBHATI","year":"2023","unstructured":"Khambhati K, Bhattacharjee G, Gohil N, Maurya, R., Singh V (2023b) Exploring the potential of phage and their applications. Prog Mol Biol Transl Sci 200:1\u201312","journal-title":"Prog Mol Biol Transl Sci"},{"key":"6393_CR76","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A KOH","year":"2016","unstructured":"Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F (2016) From dietary fiber to host physiology: Short-Chain fatty acids as key bacterial metabolites. Cell 165:1332\u20131345","journal-title":"Cell"},{"key":"6393_CR77","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/1574-6976.12072","volume":"38","author":"B KOSKELLA","year":"2014","unstructured":"Koskella B, Brockhurst MA (2014) Bacteria-phage Coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol Rev 38:916\u2013931","journal-title":"FEMS Microbiol Rev"},{"key":"6393_CR78","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","volume":"11","author":"R KRISHNA","year":"2000","unstructured":"Krishna R, Mayer LD (2000) Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11:265\u2013283","journal-title":"Eur J Pharm Sci"},{"key":"6393_CR79","doi-asserted-by":"publisher","first-page":"2481178","DOI":"10.1080\/19490976.2025.2481178","volume":"17","author":"E KURILOVICH","year":"2025","unstructured":"Kurilovich E, Geva-Zatorsky N (2025) Effects of bacteriophages on gut Microbiome functionality. Gut Microbes 17:2481178","journal-title":"Gut Microbes"},{"key":"6393_CR80","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","volume":"8","author":"SJ LABRIE","year":"2010","unstructured":"Labrie SJ, Samson, J. E., Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317\u2013327","journal-title":"Nat Rev Microbiol"},{"key":"6393_CR81","doi-asserted-by":"crossref","unstructured":"Lauman P, Dennis JJ (2021) Advances in phage therapy: targeting the burkholderia Cepacia complex. Viruses, 13","DOI":"10.3390\/v13071331"},{"key":"6393_CR82","doi-asserted-by":"publisher","first-page":"e68562","DOI":"10.1371\/journal.pone.0068562","volume":"8","author":"S LE","year":"2013","unstructured":"Le S, He X, Huang Tany, Zhang G, Shi LLUXR, W., Hu F (2013) Mapping the tail fiber as the receptor binding protein responsible for differential host specificity of Pseudomonas aeruginosa bacteriophages PaP1 and JG004. PLoS ONE 8:e68562","journal-title":"PLoS ONE"},{"key":"6393_CR83","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.copbio.2012.08.005","volume":"24","author":"JG LEBLANC","year":"2013","unstructured":"Leblanc JG, Milani C, De Giori GS, Sesma F, Van Sinderen D, Ventura M (2013) Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24:160\u2013168","journal-title":"Curr Opin Biotechnol"},{"key":"6393_CR84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.copbio.2020.11.003","volume":"68","author":"BR LENNEMAN","year":"2021","unstructured":"Lenneman BR, Loessner Fernbachj, Lu MJ, Kilcher S (2021) Enhancing phage therapy through synthetic biology and genome engineering. Curr Opin Biotechnol 68:151\u2013159","journal-title":"Curr Opin Biotechnol"},{"key":"6393_CR86","doi-asserted-by":"crossref","unstructured":"Lin J, Du, F., Long, M., Li P (2022) Limitations of phage therapy and corresponding optimization strategies: A review. Molecules, 27","DOI":"10.3390\/molecules27061857"},{"key":"6393_CR85","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","volume":"8","author":"DM LIN","year":"2017","unstructured":"Lin DM, Koskella B, Lin HC (2017) Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 8:162\u2013173","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"6393_CR90","doi-asserted-by":"publisher","first-page":"558799","DOI":"10.3389\/fcimb.2020.558799","volume":"10","author":"X LIU","year":"2020","unstructured":"Liu X, Ruan Zouy, Chen MCHANGL, Wang X, Yang S, Zhang W, Guo L, Chen Y, Zhang Y, He Y, Wang HGANY, Zhu X (2020) Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota. Front Cell Infect Microbiol 10:558799","journal-title":"Front Cell Infect Microbiol"},{"key":"6393_CR87","doi-asserted-by":"crossref","unstructured":"Liu D, Van Belleghem JD, De Vries CR, Burgener E, Chen Q, Manasherob, R., Aronson, J. R., Amanatullah, D. F., Tamma, P. D., Suh GA (2021) The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies. Viruses, 13","DOI":"10.20944\/preprints202105.0231.v1"},{"key":"6393_CR88","first-page":"20230092","volume":"4","author":"H LIU","year":"2024","unstructured":"Liu H, Dong YUY, Elsabahy A, Yang M, Gao H (2024a) Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: systematic review, improvements and future challenges. Explor (Beijing) 4:20230092","journal-title":"Explor (Beijing)"},{"key":"6393_CR89","doi-asserted-by":"publisher","first-page":"1336821","DOI":"10.3389\/fcimb.2024.1336821","volume":"14","author":"K LIU","year":"2024","unstructured":"Liu K, Wang C, Guo Zhoux, Yang X, Liu Y, Zhao W, R., Song H (2024b) Bacteriophage therapy for drug-resistant Staphylococcus aureus infections. Front Cell Infect Microbiol 14:1336821","journal-title":"Front Cell Infect Microbiol"},{"key":"6393_CR91","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1128\/aem.62.4.1133-1140.1996","volume":"62","author":"MJ LOESSNER","year":"1996","unstructured":"Loessner MJ, Rees CE, Stewart GS, Scherer S (1996) Construction of luciferase reporter bacteriophage A511::luxAB for rapid and sensitive detection of viable Listeria cells. Appl Environ Microbiol 62:1133\u20131140","journal-title":"Appl Environ Microbiol"},{"key":"6393_CR92","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/B978-0-12-394621-8.00019-4","volume":"82","author":"M \u0141O\u015a","year":"2012","unstructured":"\u0141o\u015b M, W\u0119grzyn G (2012) Pseudolysogeny. Adv Virus Res 82:339\u2013349","journal-title":"Adv Virus Res"},{"key":"6393_CR93","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1007\/s00216-024-05301-0","volume":"416","author":"J LUO","year":"2024","unstructured":"Luo J, Xu D, Liu Wangj, Li H, Zhang Y, Zeng Y, H., Deng, B., Liu X (2024) A Dual-mode platform for the rapid detection of Escherichia coli O157:H7 based on CRISPR\/Cas12a and RPA. Anal Bioanal Chem 416:3509\u20133518","journal-title":"Anal Bioanal Chem"},{"key":"6393_CR94","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","volume":"42","author":"T LUONG","year":"2020","unstructured":"Luong T, Salabarria, A. C., Roach DR (2020) Phage therapy in the resistance era: where do we stand and where are we going? Clin Ther 42:1659\u20131680","journal-title":"Clin Ther"},{"key":"6393_CR95","doi-asserted-by":"crossref","unstructured":"Mafe AN, B\u00fcsselberg D (2025) Phage therapy in managing Multidrug-Resistant (MDR) infections in cancer therapy: Innovations, Complications, and future directions. Pharmaceutics, 17","DOI":"10.3390\/pharmaceutics17070820"},{"key":"6393_CR96","doi-asserted-by":"publisher","first-page":"210188","DOI":"10.1098\/rsob.210188","volume":"11","author":"S M\u00c4NTYNEN","year":"2021","unstructured":"M\u00e4ntynen S, Laanto E, Oksanen HM, Poranen MM, D\u00edaz-Mu\u00f1oz SL (2021) Black box of phage-bacterium interactions: exploring alternative phage infection strategies. Open Biol 11:210188","journal-title":"Open Biol"},{"key":"6393_CR97","doi-asserted-by":"publisher","first-page":"106004","DOI":"10.1016\/j.isci.2023.106004","volume":"26","author":"J MARCHI","year":"2023","unstructured":"Marchi J, Zborowsky S, Debarbieux L, Weitz JS (2023) The dynamic interplay of bacteriophage, bacteria and the mammalian host during phage therapy. iScience 26:106004","journal-title":"iScience"},{"key":"6393_CR98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4161\/bact.18778","volume":"2","author":"LJ MARINELLI","year":"2012","unstructured":"Marinelli LJ, Hatfull, G. F., Piuri M (2012) Recombineering: A powerful tool for modification of bacteriophage genomes. Bacteriophage 2:5\u201314","journal-title":"Bacteriophage"},{"key":"6393_CR99","doi-asserted-by":"crossref","unstructured":"Mathewson ND, Mathew Jenqr, Koenigsknecht AV, Hanash M, Toubai A, Oravecz-Wilson T, Sun Kwusr, Rossi Y, Fujiwara C, Shono HBYUNJ, Lindemans Y, Calafiore C, Honda MSCHMIDTTM, Young K, Van VB, Den Brink M, Reddy P (2016) Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol, 17, 505\u2013513","DOI":"10.1038\/ni.3400"},{"key":"6393_CR100","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/srep00233","volume":"2","author":"M MATSUMOTO","year":"2012","unstructured":"Matsumoto M, Ooga Kiber, Aiba T, Kurihara Y, Sawaki S, Koga E, Y., Benno Y (2012) Impact of intestinal microbiota on intestinal luminal metabolome. Sci Rep 2:233","journal-title":"Sci Rep"},{"key":"6393_CR102","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","volume":"9","author":"A MAYORGA-RAMOS","year":"2023","unstructured":"Mayorga-Ramos A, Z\u00fa\u00f1iga-Miranda J, Carrera-Pacheco SE, Barba-Ostria C, Guam\u00e1n LP (2023) CRISPR-Cas-Based antimicrobials: Design, Challenges, and bacterial mechanisms of resistance. ACS Infect Dis 9:1283\u20131302","journal-title":"ACS Infect Dis"},{"key":"6393_CR101","doi-asserted-by":"crossref","unstructured":"Mayorga-Ramos A, Carrera-Pacheco SE, Barba-Ostria C, Guam\u00e1n LP (2024) Bacteriophage-mediated approaches for biofilm control. Front Cell Infect Microbiol, Volume 14\u20132024","DOI":"10.3389\/fcimb.2024.1428637"},{"key":"6393_CR103","doi-asserted-by":"publisher","first-page":"e22676","DOI":"10.1096\/fj.202201591R","volume":"37","author":"S MIYASATO","year":"2023","unstructured":"Miyasato S, Iwata K, Mura R, Nakamura S, Yanagida K, Shindou H, Nagata Y, Kawahara M, Inoue Yamaguchisaokij, Nagamune A, Shimizu T, T., Nakamura M (2023) Constitutively active GPR43 is crucial for proper leukocyte differentiation. Faseb J 37:e22676","journal-title":"Faseb J"},{"key":"6393_CR104","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E MONTASSIER","year":"2015","unstructured":"Montassier E, Gastinne T, Al-Ghalith Vangayp, Bruley GA, Des Varannes S, Massart S, Moreau P, Potel G, De La Cocheti\u00e8re MF, Batard E, Knights D (2015) Chemotherapy-driven dysbiosis in the intestinal Microbiome. Aliment Pharmacol Ther 42:515\u2013528","journal-title":"Aliment Pharmacol Ther"},{"key":"6393_CR105","first-page":"e2020024","volume":"91","author":"Z NAUREEN","year":"2020","unstructured":"Naureen Z, Dautaj A, Anpilogov K, Camilleri G, Dhuli K, Tanzi B, Maltese PE, Cristofoli F, De Antoni L, Beccari T, Dundar M, Bertelli M (2020) Bacteriophages presence in nature and their role in the natural selection of bacterial populations. Acta Biomed 91:e2020024","journal-title":"Acta Biomed"},{"key":"6393_CR106","doi-asserted-by":"publisher","first-page":"23858","DOI":"10.1038\/s41598-024-75456-4","volume":"14","author":"P NONEJUIE","year":"2024","unstructured":"Nonejuie P, Wilantho A, Mcdonald D, Chalerm H, Ngamphiw JTRIPATHIA, Tongsima C, Paiboonsukwong Sknightr, K., Fucharoen S (2024) Differential gut microbiota composition in \u03b2-Thalassemia patients and its correlation with iron overload. Sci Rep 14:23858","journal-title":"Sci Rep"},{"key":"6393_CR107","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/erm.2013.3","volume":"15","author":"SL NOWOTARSKI","year":"2013","unstructured":"Nowotarski SL, Woster PM, Casero RA, JR (2013) Polyamines and cancer: implications for chemotherapy and chemoprevention. Expert Rev Mol Med 15:e3","journal-title":"Expert Rev Mol Med"},{"key":"6393_CR108","doi-asserted-by":"crossref","unstructured":"Okolie MC, Ainyanbhor Edogi, Jikah IE, Zainulabdeen Anakpogheliepoyousife, Isoje KEF, Igbuku, UA, Orogu JO, Owheruo JO, Essaghah AEA., Umar H (2025) Gut microbiota and immunity in health and diseases: a review. Proceedings of the Indian National Science Academy, 91, 397\u2013414","DOI":"10.1007\/s43538-024-00355-1"},{"key":"6393_CR109","doi-asserted-by":"publisher","first-page":"107088","DOI":"10.1016\/j.micpath.2024.107088","volume":"197","author":"DB OLAWADE","year":"2024","unstructured":"Olawade DB, Egbon Fapohundao, Usman Eebiesuwaoa, S. O., Faronbi, A. O., Fidelis SC (2024) Phage therapy: A targeted approach to overcoming antibiotic resistance. Microb Pathog 197:107088","journal-title":"Microb Pathog"},{"key":"6393_CR110","doi-asserted-by":"crossref","unstructured":"Onallah H, et al. (2023) Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series. Med, 4, 600\u2013611.e4","DOI":"10.2139\/ssrn.4443497"},{"key":"6393_CR111","doi-asserted-by":"crossref","unstructured":"Peled JU, (2020) Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med, 382, 822\u2013834","DOI":"10.1056\/NEJMc2006694"},{"key":"6393_CR112","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1128\/MMBR.00069-15","volume":"80","author":"DP PIRES","year":"2016","unstructured":"Pires DP, Cleto S, Sillankorva S, Azeredo, J., Lu TK (2016) Genetically engineered phages: a review of advances over the last decade. Microbiol Mol Biol Rev 80:523\u2013543","journal-title":"Microbiol Mol Biol Rev"},{"key":"6393_CR113","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1038\/s41467-024-46555-7","volume":"15","author":"M PODLACHA","year":"2024","unstructured":"Podlacha M, Gaffke L, Grabski Grabowski\u0142mantejj, Pierzchalska M, Pierzynowska M, W\u0119grzyn K, G., W\u0119grzyn A (2024) Bacteriophage DNA induces an interrupted immune response during phage therapy in a chicken model. Nat Commun 15:2274","journal-title":"Nat Commun"},{"key":"6393_CR114","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.clnu.2023.09.021","volume":"42","author":"SA P\u00d6TGENS","year":"2023","unstructured":"P\u00f6tgens SA, Lecop S, Havelange V, Li F, Neyrinck AM, Schoemans Neveuxnmaertensjwalterj H., Delzenne NM, Bindels LB (2023) Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss. Clin Nutr 42:2214\u20132228","journal-title":"Clin Nutr"},{"key":"6393_CR115","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1016\/j.cell.2021.06.007","volume":"PEARCE","author":"DJ PULESTON","year":"2021","unstructured":"Puleston DJ, Baixauli F, Edwards-Hicks Saninde, Villa J, Kabat M, Kami\u0144ski AM, Stanckzak MM, Grzes Mweisshj, Field Kmpiletick, Corrado CS, Haessler M, Wang F, Musa C, Schimmelpfennig Y, L., Flachsmann, L., Mittler, G., Green Vkbuescherjmbalabanovspearceej (2021) Polyamine metabolism is a central determinant of helper T cell lineage fidelity. Cell D. R. & PEARCE:184, 4186\u20134202e20, YOSEF, N., KUCHROO,","journal-title":"Cell"},{"key":"6393_CR116","doi-asserted-by":"publisher","first-page":"19039","DOI":"10.1073\/pnas.0609428103","volume":"103","author":"U QIMRON","year":"2006","unstructured":"Qimron U, Tabor Marintchevab, S., Richardson CC (2006) Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage. Proc Natl Acad Sci U S A 103:19039\u201319044","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6393_CR117","doi-asserted-by":"crossref","unstructured":"Ragothaman M, Yoo SY (2023) Engineered Phage-Based cancer vaccines: current advances and future directions. Vaccines (Basel), 11","DOI":"10.3390\/vaccines11050919"},{"key":"6393_CR118","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41467-025-56375-y","volume":"16","author":"S REDDI","year":"2025","unstructured":"Reddi S, Senyshyn L, Ebadi M, Podlesny D, Minot SS, Gooley T, Lee Kabageajhillgr, Khoruts SJ, A., Rashidi A (2025) Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect. Nat Commun 16:1034","journal-title":"Nat Commun"},{"key":"6393_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"I ROWLAND","year":"2018","unstructured":"Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57:1\u201324","journal-title":"Eur J Nutr"},{"key":"6393_CR120","doi-asserted-by":"crossref","unstructured":"Royo-Cebrecos C, et al. (2024) Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy. Microorganisms, 12, 705","DOI":"10.3390\/microorganisms12040705"},{"key":"6393_CR121","doi-asserted-by":"publisher","first-page":"100534","DOI":"10.1016\/j.microb.2025.100534","volume":"8","author":"M SAHU","year":"2025","unstructured":"Sahu M, Singh SK, Singh M, Shukla, A., Nath G (2025) Bacteriophage therapy a promising alternative treatment approach for infections caused by multidrug-resistant (MDR) Enterococcus species. Microbe 8:100534","journal-title":"Microbe"},{"key":"6393_CR122","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrmicro3564","volume":"13","author":"GP SALMOND","year":"2015","unstructured":"Salmond GP, Fineran PC (2015) A century of the phage: past, present and future. Nat Rev Microbiol 13:777\u2013786","journal-title":"Nat Rev Microbiol"},{"key":"6393_CR123","first-page":"602","volume":"16","author":"C SARAH","year":"2017","unstructured":"Sarah C (2017) Anticancer agents: fighting resistance. Nat Rev Drug Discov 16:602","journal-title":"Nat Rev Drug Discov"},{"key":"6393_CR124","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40560-024-00759-7","volume":"12","author":"T SAWA","year":"2024","unstructured":"Sawa T, Moriyama K, Kinoshita M (2024) Current status of bacteriophage therapy for severe bacterial infections. J Intensive Care 12:44","journal-title":"J Intensive Care"},{"key":"6393_CR125","doi-asserted-by":"publisher","first-page":"670286","DOI":"10.3389\/fimmu.2021.670286","volume":"12","author":"ML SCHUBERT","year":"2021","unstructured":"Schubert ML, Rohrbach R, Schmitt M, Stein-Thoeringer CK (2021) The potential role of the intestinal micromilieu and individual microbes in the immunobiology of chimeric antigen receptor T-Cell therapy. Front Immunol 12:670286","journal-title":"Front Immunol"},{"key":"6393_CR126","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1158\/1078-0432.CCR-22-0723","volume":"LESOKHIN","author":"UA SHAH","year":"2022","unstructured":"Shah UA et al. (2022) Sustained minimal residual disease negativity in multiple myeloma is associated with stool butyrate and healthier Plant-Based diets. Clin Cancer Res LESOKHIN:28, 5149\u20135155","journal-title":"Clin Cancer Res"},{"key":"6393_CR127","doi-asserted-by":"crossref","unstructured":"Sham HP, Bazett M, Bosiljcic M, Yang H, Luk B, Law HT, Morampudi V, Pankovich YUHB, Sutcliffe J, Bressler S, Fedorak Bmarshalljk, Chen RN, Gunn Jjonesm H, Kalyan, S., Vallance BA (2018) Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis. Front Immunol, 9, 2211","DOI":"10.3389\/fimmu.2018.02211"},{"key":"6393_CR128","doi-asserted-by":"publisher","first-page":"e0009021","DOI":"10.1128\/Spectrum.00090-21","volume":"9","author":"S SHEN","year":"2021","unstructured":"Shen S, Huo D, Jiang Mac, S., Zhang J (2021) Expanding the colorectal cancer biomarkers based on the human gut phageome. Microbiol Spectr 9:e0009021","journal-title":"Microbiol Spectr"},{"key":"6393_CR129","doi-asserted-by":"crossref","unstructured":"Shono Y et al. (2016) Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med M. R. M. & JENQ:8, 339ra71","DOI":"10.1126\/scitranslmed.aaf2311"},{"key":"6393_CR130","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2147\/IDR.S348700","volume":"15","author":"A SINGH","year":"2022","unstructured":"Singh A, Padmesh S, Dwivedi M, Kostova I (2022) How good are bacteriophages as an alternative therapy to mitigate biofilms of nosocomial infections. Infect Drug Resist 15:503\u2013532","journal-title":"Infect Drug Resist"},{"key":"6393_CR131","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1182\/blood-2017-08-752121","volume":"131","author":"M SMITH","year":"2018","unstructured":"Smith M, Zakrzewski J, James S, Sadelain M (2018) Posttransplant chimeric antigen receptor therapy. Blood 131:1045\u20131052","journal-title":"Blood"},{"key":"6393_CR132","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12967-025-06797-5","volume":"23","author":"H SOLEIMANI SAMARKHAZAN","year":"2025","unstructured":"Soleimani Samarkhazan H, Nouri S, Maleknia M, Aghaei M (2025) The Microbiome in graft-versus-host disease: a Tale of two ecosystems. J Translational Med 23:832","journal-title":"J Translational Med"},{"key":"6393_CR133","doi-asserted-by":"publisher","first-page":"74","DOI":"10.21037\/atm-23-1806","volume":"12","author":"Y SONG","year":"2024","unstructured":"Song Y, Gyarmati P (2024) Potential role of short-chain fatty acids in the pathogenesis and management of acute lymphocytic leukemia. Ann Transl Med 12:74","journal-title":"Ann Transl Med"},{"key":"6393_CR134","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cclet.2021.08.090","volume":"33","author":"Y SONG","year":"2022","unstructured":"Song Y, Huang Y, Zhou F, Ding J, Zhou W (2022) Macrophage-targeted nanomedicine for chronic diseases immunotherapy. Chin Chem Lett 33:597\u2013612","journal-title":"Chin Chem Lett"},{"key":"6393_CR135","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA STRATHDEE","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik, V. K., Schooley RT (2023) Phage therapy: from biological mechanisms to future directions. Cell 186:17\u201331","journal-title":"Cell"},{"key":"6393_CR136","doi-asserted-by":"crossref","unstructured":"Subramanian A (2024) Emerging roles of bacteriophage-based therapeutics in combating antibiotic resistance. Front Microbiol, Volume 15\u20132024","DOI":"10.3389\/fmicb.2024.1384164"},{"key":"6393_CR137","doi-asserted-by":"publisher","first-page":"113392","DOI":"10.1016\/j.intimp.2024.113392","volume":"144","author":"D-Y SUN","year":"2025","unstructured":"Sun D-Y, Li H-J, Dai Xpengj, Z.-J., Wang S (2025a) Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies. Int Immunopharmacol 144:113392","journal-title":"Int Immunopharmacol"},{"key":"6393_CR138","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41522-025-00678-x","volume":"11","author":"J SUN","year":"2025","unstructured":"Sun J, Song S, Liu J, Chen F, Li X, Wu G (2025b) Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation. Npj Biofilms Microbiomes 11:43","journal-title":"Npj Biofilms Microbiomes"},{"key":"6393_CR139","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/cac2.12525","volume":"44","author":"L TANG","year":"2024","unstructured":"Tang L, Zhang H, Du Zhoufweiq, Wu M, Li J, Luo C, Wang Wzhouj, Chen X, Zhang Z, Huang Y, Wu Z, Wen Z, Kou Yjianghliaod, Mei Hxiongw, H., Hu Y (2024) Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies. Cancer Commun (Lond) 44:408\u2013432","journal-title":"Cancer Commun (Lond)"},{"key":"6393_CR140","doi-asserted-by":"crossref","unstructured":"Taslem Mourosi J, Guo Awea, Batra W, Ganesh H, Wu H, X., Zhu J (2022) Understanding bacteriophage tail fiber interaction with host surface receptor: the key blueprint for reprogramming phage host range. Int J Mol Sci, 23","DOI":"10.3390\/ijms232012146"},{"key":"6393_CR141","doi-asserted-by":"crossref","unstructured":"Taur Y et al. (2018) Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med, 10","DOI":"10.1126\/scitranslmed.aap9489"},{"key":"6393_CR142","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/ecco-jcc\/jjac064","volume":"16","author":"M TIT\u00c9CAT","year":"2022","unstructured":"Tit\u00e9cat M, Dubuquoy Rousseauxc, Folign\u00e9 C, Rahmouni B, Mahieux O, Desreumaux S, Wannerberger Pwoolstonjsulakvelidzea, K., Neut C (2022) Safety and efficacy of an AIEC-targeted bacteriophage cocktail in a mice colitis model. J Crohns Colitis 16:1617\u20131627","journal-title":"J Crohns Colitis"},{"key":"6393_CR143","doi-asserted-by":"crossref","unstructured":"Torres-Barcel\u00f3 C (2018) Phage therapy faces evolutionary challenges. Viruses, 10","DOI":"10.3390\/v10060323"},{"key":"6393_CR144","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3444","volume":"20","author":"A TROMPETTE","year":"2014","unstructured":"Trompette A, Yadava Gollwitzeres, Sprenger Ksichelstielak, Ngom-Bru N, Blanchard C, Junt C, T., Nicod, L. P., Harris, N. L., Marsland BJ (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20:159\u2013166","journal-title":"Nat Med"},{"key":"6393_CR145","doi-asserted-by":"crossref","unstructured":"Tsegaye K, Tsehai, B. A., Getie B (2024) Desirable L-asparaginases for treating cancer and current research trends. Front Microbiol, Volume 15\u20132024","DOI":"10.3389\/fmicb.2024.1269282"},{"key":"6393_CR146","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40262-021-01032-y","volume":"60","author":"SM TSUNODA","year":"2021","unstructured":"Tsunoda SM, Gonzales C, Momper Jarmuschak, J. D., Ma JD (2021) Contribution of the gut Microbiome to drug Disposition, Pharmacokinetic and pharmacodynamic variability. Clin Pharmacokinet 60:971\u2013984","journal-title":"Clin Pharmacokinet"},{"key":"6393_CR147","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/antibiotics14070629","volume":"14","author":"KD URGEYA","year":"2025","unstructured":"Urgeya KD, Subedi D, Kumar N, Willcox M (2025) The ability of bacteriophages to reduce biofilms produced by Pseudomonas aeruginosa isolated from corneal infections. Antibiotics 14:629","journal-title":"Antibiotics"},{"key":"6393_CR148","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N VASAN","year":"2019","unstructured":"Vasan N, Baselga, J., Hyman DM (2019) A view on drug resistance in cancer. Nature 575:299\u2013309","journal-title":"Nature"},{"key":"6393_CR149","doi-asserted-by":"crossref","unstructured":"Vila M, Balc\u00e3o LMN, Balc\u00e3o VM (2024) Phage delivery strategies for biocontrolling Human, Animal, and plant bacterial infections: state of the Art. Pharmaceutics, 16","DOI":"10.3390\/pharmaceutics16030374"},{"key":"6393_CR150","doi-asserted-by":"crossref","unstructured":"Villanueva-Flores F, Pastor, A. R., Palomares, L. A., Huerta-Saquero A (2023) A novel formulation of asparaginase encapsulated into Virus-like particles of brome mosaic virus: in vitro and in vivo evidence. Pharmaceutics, 15","DOI":"10.3390\/pharmaceutics15092260"},{"key":"6393_CR151","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A WAHLSTR\u00d6M","year":"2016","unstructured":"Wahlstr\u00f6m A, Marschall Sayinsi, H. U., B\u00e4ckhed F (2016) Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 24:41\u201350","journal-title":"Cell Metab"},{"key":"6393_CR153","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1038\/s41467-022-30240-8","volume":"13","author":"R WANG","year":"2022","unstructured":"Wang R, Yang X, Zhong LIUJ, Zhang F, Chen C, Y., Sun, T., Ji, C., MA D (2022) Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun 13:2522","journal-title":"Nat Commun"},{"key":"6393_CR152","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s12951-024-02576-4","volume":"22","author":"H WANG","year":"2024","unstructured":"Wang H, Yang Y, Xu Y, Chen Y, Zhang W, Liu T, Chen G, Wang K (2024a) Phage-based delivery systems: engineering, applications, and challenges in nanomedicines. J Nanobiotechnol 22:365","journal-title":"J Nanobiotechnol"},{"key":"6393_CR155","doi-asserted-by":"publisher","first-page":"16484","DOI":"10.1021\/acs.jafc.4c02433","volume":"72","author":"Z WANG","year":"2024","unstructured":"Wang Z, Li L, Li W, Yan H, & Yuan Y (2024b) Salidroside alleviates Furan-Induced impaired gut barrier and inflammation via gut Microbiota-SCFA-TLR4 signaling. J Agric Food Chem 72:16484\u201316495","journal-title":"J Agric Food Chem"},{"key":"6393_CR156","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/imm.13793","volume":"173","author":"ZB WANG","year":"2024","unstructured":"Wang ZB, Zhang X, Liu Fangc, Wu Xtliaoqj, N., Wang J (2024c) Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy. Immunology 173:14\u201332","journal-title":"Immunology"},{"key":"6393_CR154","doi-asserted-by":"crossref","unstructured":"Wang W-X, Chen Y-Y, Fu X-Z, Li S-Y, Gu S.-L., Gao, J.-H., Fan, J., Sun, Y.-M., Feng, J., Wang, S.-W., Chen W (2025) Prophylactic phage administration provides a time window for delayed treatment of vancomycin-resistant Enterococcus faecalis in a murine bacteremia model. Front Microbiol, Volume 15\u20132024","DOI":"10.3389\/fmicb.2024.1504696"},{"key":"6393_CR157","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2024.01.005","volume":"213","author":"Y WEI","year":"2024","unstructured":"Wei Y, Liu W, Chen Wangr, Liu Y, Guo J, Yang Xcanc, Wang X, D., Hu, X., Ma D (2024) Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity. Free Radic Biol Med 213:36\u201351","journal-title":"Free Radic Biol Med"},{"key":"6393_CR159","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1007\/s12035-023-03911-w","volume":"61","author":"X WU","year":"2024","unstructured":"Wu X, Ge Fum, Huang Czhouh, Zhong H, Zhang M, Xu M, Zhu H, LV Ghuaw, K., YANG H (2024) m(6)A-Mediated upregulation of LncRNA CHASERR promotes the progression of glioma by modulating the miR-6893-3p\/TRIM14 axis. Mol Neurobiol 61:5418\u20135440","journal-title":"Mol Neurobiol"},{"key":"6393_CR158","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/cac2.70048","volume":"45","author":"T WU","year":"2025","unstructured":"Wu T, Zhao Y, Zhang X, Wang Y, Chen Q, Zhang M, Zhang Shengh, Guo Y, Li J, Wang Jfany, Li Z, Wei Ywangh, M., Hu, X., Wu H (2025) Short-chain acyl post-translational modifications in cancers: Mechanisms, roles, and therapeutic implications. Cancer Commun (Lond) 45:1247\u20131284","journal-title":"Cancer Commun (Lond)"},{"key":"6393_CR160","doi-asserted-by":"publisher","first-page":"127007","DOI":"10.1016\/j.biortech.2022.127007","volume":"351","author":"L XU","year":"2022","unstructured":"Xu L, Wang GUJ, Song X, Jiang Z, Li H, Xie N, Ding JHUT, Q., Sun Y (2022) Risk of horizontal transfer of intracellular, extracellular, and bacteriophage antibiotic resistance genes during anaerobic digestion of cow manure. Bioresour Technol 351:127007","journal-title":"Bioresour Technol"},{"key":"6393_CR161","doi-asserted-by":"publisher","first-page":"129332","DOI":"10.1016\/j.ijbiomac.2024.129332","volume":"260","author":"H YANG","year":"2024","unstructured":"Yang H, Xu Zhouhfum, Huang H, Zhong H, Zhang M, Lv Mhuaw, K., ZHU G (2024) TMEM64 aggravates the malignant phenotype of glioma by activating the Wnt\/\u03b2-catenin signaling pathway. Int J Biol Macromol 260:129332","journal-title":"Int J Biol Macromol"},{"key":"6393_CR162","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3390\/jcm9051498","volume":"9","author":"J YANG ZHOU","year":"2020","unstructured":"Yang Zhou J, Suwan K, Hajitou A (2020) Initial steps for the development of a Phage-Mediated gene replacement therapy using CRISPR-Cas9 technology. J Clin Med 9:1498","journal-title":"J Clin Med"},{"key":"6393_CR163","doi-asserted-by":"crossref","unstructured":"Yeldag G, Rice A, Del R\u00edo Hern\u00e1ndez A (2018) Chemoresistance and the Self-Maintaining tumor microenvironment. Cancers (Basel), 10","DOI":"10.3390\/cancers10120471"},{"key":"6393_CR164","doi-asserted-by":"crossref","unstructured":"Yoganathan S, Alagaratnam A, Acharekar N, Kong J (2021) Ellagic acid and schisandrins: natural biaryl polyphenols with therapeutic potential to overcome multidrug resistance in cancer. Cells, 10","DOI":"10.3390\/cells10020458"},{"key":"6393_CR165","doi-asserted-by":"crossref","unstructured":"Yoo JY, Groer M, Dutra Svo, Sarkar A, Mcskimming Di (2020) Gut microbiota and immune system interactions. Microorganisms, 8","DOI":"10.3390\/microorganisms8101587"},{"key":"6393_CR166","doi-asserted-by":"crossref","unstructured":"Young J, Shariyate Leesw, Cronin MJ, Nazarian Awixtedjj, A., Rowley, C. F., Rodriguez EK (2024) Bacteriophage therapy and current delivery strategies for orthopedic infections: A SCOPING review. J Infect, 88","DOI":"10.1016\/j.jinf.2024.106125"},{"key":"6393_CR167","doi-asserted-by":"publisher","first-page":"2307542","DOI":"10.1080\/19490976.2024.2307542","volume":"16","author":"X YU","year":"2024","unstructured":"Yu X, Wang Ouj, Li L, Ren Z, Xie Y, Chen L, Liang Z, Shen J, Zou G, Zhao Z, Li C, G., Hu Y (2024) Gut microbiota modulate CD8(+) T cell immunity in gastric cancer through Butyrate\/GPR109A\/HOPX. Gut Microbes 16:2307542","journal-title":"Gut Microbes"},{"key":"6393_CR168","doi-asserted-by":"crossref","unstructured":"Zalewska-Pi\u0105tek B (2023) Phage Therapy-Challenges, opportunities and future prospects. Pharmaceuticals (Basel), 16","DOI":"10.3390\/ph16121638"},{"key":"6393_CR169","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T ZELANTE","year":"2013","unstructured":"Zelante T, De Luca Iannittirgcunhac, Giovannini A, Pieraccini G, Zecchi G, D\u2019Angelo R, Massi-benedetti C, Carvalho Cfallarinof, Puccetti A, P., Romani L (2013) Tryptophan catabolites from microbiota engage Aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372\u2013385","journal-title":"Immunity"},{"key":"6393_CR170","doi-asserted-by":"crossref","unstructured":"Zhai B, Rolling Olam, Tosini T, Joshowitz NL, Littmann S, Wright Eramorettilafontanae, Miranda RJ, Morjaria Eveelkenca, S. M., Peled, J. U., Hohl TM (2020) High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat Med 26:59\u201364","DOI":"10.1038\/s41591-019-0709-7"},{"key":"6393_CR171","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/jcp.30064","volume":"236","author":"B ZHANG","year":"2021","unstructured":"Zhang B (2021) CRISPR\/Cas gene therapy. J Cell Physiol 236:2459\u20132481","journal-title":"J Cell Physiol"},{"key":"6393_CR172","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhang T, Chen Yum, Y. L., Jin M (2022) The life cycle transitions of temperate phages: regulating factors and potential ecological implications. Viruses, 14","DOI":"10.3390\/v14091904"},{"key":"6393_CR174","doi-asserted-by":"publisher","first-page":"103016","DOI":"10.1016\/j.redox.2023.103016","volume":"69","author":"Y ZHANG","year":"2024","unstructured":"Zhang Y, Zhu L, Li X, Ge C, Pei W, Zhang M, Zhong M, Zhu X, Lv K (2024) M2 macrophage exosome-derived LncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages. Redox Biol 69:103016","journal-title":"Redox Biol"},{"key":"6393_CR173","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.2147\/JIR.S499403","volume":"18","author":"S ZHANG","year":"2025","unstructured":"Zhang S, Chen W, Liang Zhouj, Zhang Q, Su Y, Zhang M, Z., Qu J (2025) The benefits and safety of monoclonal antibodies: implications for cancer immunotherapy. J Inflamm Res 18:4335\u20134357","journal-title":"J Inflamm Res"},{"key":"6393_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000355895","volume":"41","author":"Y ZHAO","year":"2014","unstructured":"Zhao Y, Adjei AA (2014) Targeting oncogenic drivers. Prog Tumor Res 41:1\u201314","journal-title":"Prog Tumor Res"},{"key":"6393_CR175","doi-asserted-by":"publisher","first-page":"1137947","DOI":"10.3389\/fcimb.2023.1137947","volume":"13","author":"A ZHAO","year":"2023","unstructured":"Zhao A, Sun, J., Liu Y (2023) Understanding bacterial biofilms: from definition to treatment strategies. Front Cell Infect Microbiol 13:1137947","journal-title":"Front Cell Infect Microbiol"},{"key":"6393_CR177","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D ZHENG","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492\u2013506","journal-title":"Cell Res"},{"key":"6393_CR178","doi-asserted-by":"crossref","unstructured":"Zhong Z, Yao R, Duan Y, Ouyang C, Du Z, Li L, Zou H, Liu Y, Xue H, Li L, Chen C (2025) Advances and challenges in targeted therapy and its combination strategies for leukemia. Biomedicines, 13","DOI":"10.3390\/biomedicines13071652"},{"key":"6393_CR179","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/sj.bmt.1705912","volume":"41","author":"A ZIRAKZADEH","year":"2008","unstructured":"Zirakzadeh A, Gastineau DA, Mandrekar JN, Johnston Burkejp, P. B., Patel R (2008) Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transpl 41:385\u2013392","journal-title":"Bone Marrow Transpl"}],"updated-by":[{"DOI":"10.1007\/s00432-026-06623-5","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000}}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06393-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06393-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06393-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:03:01Z","timestamp":1789642981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06393-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6393"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06393-6","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00432-026-06623-5","URL":"https:\/\/doi.org\/10.1007\/s00432-026-06623-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a narrative review and does not contain any studies with human participants or animals performed by the author.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"8"}}